Our data from ex vivo infections of human whole blood (Fig. 6) as well from in vivo mouse infections (Fig. 7) suggest the enticing possibility that C5aR1 might be a therapeutic target for adjunctive treatment of N. meningitidis sepsis. The gene discussed is C5AR1; the disease is Sepsis.